Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tsai-Turton M et al. - Type II, but not type I, ovarian carcinoma patients had elevated serum levels of p53 AAb. P53 AAb is associated with mutation of TP53, higher plasma IL4 and IL12 but lower plasma IL8 levels and no survival advantage.

Related Articles

Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer
BMC Cancer, 11/04/09    Relevance Score: 66%

Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis
Cancer Chemotherapy and Pharmacology, 10/15/09    Relevance Score: 47%

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09    Relevance Score: 46%

Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis
Fertility and Sterility, 10/14/09    Relevance Score: 46%

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09    Relevance Score: 45%

Today in Carcinogenesis...keeping you current

Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Oncogene, 11/25/09

Association of rare MSH6 variants with familial breast cancer
Breast Cancer Research and Treatment, 11/25/09

APC promoter hypermethylation is an early event in endometrial tumorigenesis
Cancer Science, 11/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address